Variation of tumor markers in 277 breast cancer cases

Asian Pacific Journal of Cancer Prevention

Volumn 5, Issue 3, 2004, Pages 291-293

  Kermani, Iraj Asvadi ^a  

^a UNIVERSITY OF TABRIZ   (Iran)

Author keywords

Breast cancer; Iran; Survival; Tumor markers

Indexed keywords

TUMOR MARKER;

ADULT; ARTICLE; BREAST TUMOR; CANCER STAGING; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MIDDLE AGED; ONSET AGE; PAGET NIPPLE DISEASE; PATHOLOGY; PROGNOSIS; TUMOR RECURRENCE;

ADULT; AGE OF ONSET; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 6044237850     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Bennett JC (2000). Cecil Text-book of Medicine, 21st Edition. Saunders Company, Philadelphia, 1373-86.
2. Citron ML (2003). Dose dense chemotherapy improves survival in breast cancer patients, compared to conventional chemotherapy. J Clin Oncol, 22, 28-34.
3. Doben J, Engelkrirk L, Fody EP (1996). Clinical Chemistry Principles, Procedures and Correlations, 3rd Edition. Lippincott, Philadelphia, 483-501.
4. Haskell CM (2001). Cancer Treatment, 5th edition. Saunders Company, Philadelphia, 507-25.
5. Molina R, Filella X, Alicarte J, et al. (2003). Prospective evaluation of CEA and CA15.3 in patients with breast cancer. Anticancer Res, 23, 1035-41.
6. Pike MC, Spicer DV, Dalimoush L, Press MF (1991). Estrogen, progesterons, normal breast cell proliferation and breast cancer risk. Epidemiology Rev, 15, 48-65.
7. Yetes JW (1995). Cancer of the Breast, 4th Edition. Saunders. Philadeilphia, 1315-6